Among individuals with a diagnosis of type 2 diabetes across the United States, income level, hemoglobin A1c, and comorbidity burden were the primary patient-level drivers of the use of newer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback